Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy (Q48793441)

15 February 2018

title

Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy (English)

1 reference

15 February 2018

author name string

M Solders

1

1 reference

15 February 2018

D A Martin

2

1 reference

15 February 2018

C Andersson

3

1 reference

15 February 2018

M Remberger

4

1 reference

15 February 2018

T Andersson

5

1 reference

15 February 2018

O Ringdén

6

1 reference

15 February 2018

G Solders

7

1 reference

15 February 2018

language of work or name

English

0 references

publication date

5 May 2014

1 reference

15 February 2018

Bone Marrow Transplantation

published in

1 reference

15 February 2018

volume

49

1 reference

15 February 2018

issue

8

1 reference

15 February 2018

page(s)

1046-1051

1 reference

15 February 2018

Clinical symptoms of adult metachromatic leukodystrophy and arylsulfatase A pseudodeficiency.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.93

Stabilization of juvenile metachromatic leukodystrophy after bone marrow transplantation: a 13-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.93

Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.93

Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.93

Improved peripheral nerve conduction, EEG and verbal IQ after bone marrow transplantation for adult metachromatic leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.93

Metachromatic leukodystrophy: an overview of current and prospective treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.93

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.93

Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.93

Metachromatic leukodystrophy: a scoring system for brain MR imaging observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.93

Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.93

Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.93

Marked clinical difference between two sibs affected with juvenile metachromatic leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.93

Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.93

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.93

Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

12 December 2020

Late juvenile metachromatic leukodystrophy treated with bone marrow transplantation; a 4-year follow-up study

1 reference

12 December 2020

Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohort

1 reference

12 December 2020

Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center

1 reference

12 December 2020

Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation

1 reference

12 December 2020

Juvenile metachromatic leukodystrophy: neurological outcome two years after bone marrow transplantation

1 reference

12 December 2020

Characteristics of the dementia in late-onset metachromatic leukodystrophy

1 reference

12 December 2020

Ten years' experience of bone marrow transplantation for Gaucher disease.

1 reference

12 December 2020

Electroneurography index: a standardized neurophysiological method to assess peripheral nerve function in patients with polyneuropathy

1 reference

12 December 2020

Metachromatic leukodystrophy manifesting as a schizophrenic disorder: computed tomographic correlation

1 reference

12 December 2020

Slow progression of juvenile metachromatic leukodystrophy 6 years after bone marrow transplantation

1 reference

12 December 2020

Long-term neuroimaging follow-up on an asymptomatic juvenile metachromatic leukodystrophy patient after hematopoietic stem cell transplantation: evidence of myelin recovery and ongoing brain maturation

1 reference

12 December 2020

Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation

1 reference

12 December 2020

Identifiers

DOI

10.1038/BMT.2014.93

1 reference

15 February 2018

1 reference

15 February 2018